181 related articles for article (PubMed ID: 37217205)
1. The causal role of C-reactive protein and interleukin-6 on anxiety and depression symptoms and life satisfaction: Mendelian randomisation analyses in the HUNT study.
Bekkevold OJ; Damås JK; Brumpton BM; Åsvold BO
Psychol Med; 2023 Dec; 53(16):7561-7568. PubMed ID: 37217205
[TBL] [Abstract][Full Text] [Related]
2. Association of brain-derived neurotrophic factor and interleukin-6 serum levels with depressive and anxiety symptoms in hemodialysis patients.
Alshogran OY; Khalil AA; Oweis AO; Altawalbeh SM; Alqudah MAY
Gen Hosp Psychiatry; 2018; 53():25-31. PubMed ID: 29727764
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study.
Kappelmann N; Arloth J; Georgakis MK; Czamara D; Rost N; Ligthart S; Khandaker GM; Binder EB
JAMA Psychiatry; 2021 Feb; 78(2):161-170. PubMed ID: 33079133
[TBL] [Abstract][Full Text] [Related]
4. Role of inflammation in depression and anxiety: Tests for disorder specificity, linearity and potential causality of association in the UK Biobank.
Ye Z; Kappelmann N; Moser S; Davey Smith G; Burgess S; Jones PB; Khandaker GM
EClinicalMedicine; 2021 Aug; 38():100992. PubMed ID: 34505025
[TBL] [Abstract][Full Text] [Related]
5. Role of Inflammation in Depressive and Anxiety Disorders, Affect, and Cognition: Genetic and Non-Genetic Findings in the Lifelines Cohort Study.
Giollabhui NM; Slaney C; Hemani G; Foley ÉM; van der Most PJ; Nolte IM; Snieder H; Smith GD; Khandaker G; Hartman CA
medRxiv; 2024 Apr; ():. PubMed ID: 38699368
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
[TBL] [Abstract][Full Text] [Related]
7. Information provision for stroke survivors and their carers.
Crocker TF; Brown L; Lam N; Wray F; Knapp P; Forster A
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001919. PubMed ID: 34813082
[TBL] [Abstract][Full Text] [Related]
8. Body mass index and inflammation in depression and treatment-resistant depression: a Mendelian randomisation study.
Karageorgiou V; Casanova F; O'Loughlin J; Green H; McKinley TJ; Bowden J; Tyrrell J
BMC Med; 2023 Sep; 21(1):355. PubMed ID: 37710313
[TBL] [Abstract][Full Text] [Related]
9. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.
Lee KS; Yoo TK; Liao L; Wang J; Chuang YC; Liu SP; Chu R; Sumarsono B
BMC Urol; 2017 Nov; 17(1):108. PubMed ID: 29162085
[TBL] [Abstract][Full Text] [Related]
10. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
Livingston G; Barber J; Rapaport P; Knapp M; Griffin M; Romeo R; King D; Livingston D; Lewis-Holmes E; Mummery C; Walker Z; Hoe J; Cooper C
Health Technol Assess; 2014 Oct; 18(61):1-242. PubMed ID: 25300037
[TBL] [Abstract][Full Text] [Related]
11. Association between depression and anxiety scores and inflammation in patients with isolated coronary artery ectasia.
Gürbüz AS; Alsancak Y; Saklı B; Düzenli MA
Turk Kardiyol Dern Ars; 2019 Jul; 47(5):365-372. PubMed ID: 31311901
[TBL] [Abstract][Full Text] [Related]
12. Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.
Ertenli I; Ozer S; Kiraz S; Apras SB; Akdogan A; Karadag O; Calguneri M; Kalyoncu U
Rheumatol Int; 2012 Feb; 32(2):323-30. PubMed ID: 21079965
[TBL] [Abstract][Full Text] [Related]
13. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
Kilic G; Kilic E; Ozgocmen S
Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
[TBL] [Abstract][Full Text] [Related]
14. Serum tumor necrosis factor-α, interleukin-1β, interleukin-6, and interleukin-17 relate to anxiety and depression risks to some extent in non-small cell lung cancer survivor.
Liu M; Li Y; Liu X
Clin Respir J; 2022 Feb; 16(2):105-115. PubMed ID: 34697903
[TBL] [Abstract][Full Text] [Related]
15. Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium.
Taylor AE; Fluharty ME; Bjørngaard JH; Gabrielsen ME; Skorpen F; Marioni RE; Campbell A; Engmann J; Mirza SS; Loukola A; Laatikainen T; Partonen T; Kaakinen M; Ducci F; Cavadino A; Husemoen LLN; Ahluwalia TS; Jacobsen RK; Skaaby T; Ebstrup JF; Mortensen EL; Minica CC; Vink JM; Willemsen G; Marques-Vidal P; Dale CE; Amuzu A; Lennon LT; Lahti J; Palotie A; Räikkönen K; Wong A; Paternoster L; Wong AP; Horwood LJ; Murphy M; Johnstone EC; Kennedy MA; Pausova Z; Paus T; Ben-Shlomo Y; Nohr EA; Kuh D; Kivimaki M; Eriksson JG; Morris RW; Casas JP; Preisig M; Boomsma DI; Linneberg A; Power C; Hyppönen E; Veijola J; Jarvelin MR; Korhonen T; Tiemeier H; Kumari M; Porteous DJ; Hayward C; Romundstad PR; Smith GD; Munafò MR
BMJ Open; 2014 Oct; 4(10):e006141. PubMed ID: 25293386
[TBL] [Abstract][Full Text] [Related]
16. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts.
Milaneschi Y; Kappelmann N; Ye Z; Lamers F; Moser S; Jones PB; Burgess S; Penninx BWJH; Khandaker GM
Mol Psychiatry; 2021 Dec; 26(12):7393-7402. PubMed ID: 34135474
[TBL] [Abstract][Full Text] [Related]
17. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.
Khandaker GM; Pearson RM; Zammit S; Lewis G; Jones PB
JAMA Psychiatry; 2014 Oct; 71(10):1121-8. PubMed ID: 25133871
[TBL] [Abstract][Full Text] [Related]
18. Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT).
Baekken PM; Skorpen F; Stordal E; Zwart JA; Hagen K
BMC Psychiatry; 2008 Jun; 8():48. PubMed ID: 18578865
[TBL] [Abstract][Full Text] [Related]
19. Applying Mendelian randomization to appraise causality in relationships between smoking, depression and inflammation.
Galan D; Perry BI; Warrier V; Davidson CC; Stupart O; Easton D; Khandaker GM; Murray GK
Sci Rep; 2022 Sep; 12(1):15041. PubMed ID: 36057695
[TBL] [Abstract][Full Text] [Related]
20. A 4-year follow-up study of syndromal and sub-syndromal anxiety and depression symptoms in the general population: the HUNT study.
Bjerkeset O; Nordahl HM; Larsson S; Dahl AA; Linaker O
Soc Psychiatry Psychiatr Epidemiol; 2008 Mar; 43(3):192-9. PubMed ID: 18064394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
